Ad-hoc | 15 February 2006 07:56

Fresenius Medical Care Announces Signing of Definitive Agreement to Divest Facilities in Connection with Renal Care Group Acquisition

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Fresenius Medical Care Announces Signing of Definitive Agreement to Divest Facilities in Connection with Renal Care Group Acquisition Fresenius Medical Care AG & Co. KGaA (“the Company”) today announced that its wholly-owned subsidiary Fresenius Medical Care Holdings, Inc. and Renal Care Group, Inc. (NYSE:RCI) have entered into a definitive agreement to sell approximately 100 dialysis clinics serving on average approximately 60 to 65 patients per clinic to National Renal Institutes, Inc., a wholly owned subsidiary of DSI Holding Company, Inc. (DSI). The execution of this agreement is an important step toward concluding the review by the United States Federal Trade Commission (FTC) of Fresenius Medical Care’s acquisition of Renal Care Group. The purchase price for the divested clinics is approximately $450 million to be paid in cash, subject to post-closing adjustments for working capital and other routine matters. The sale of the clinics is expected to close shortly after the completion of Fresenius Medical Care’s acquisition of Renal Care Group, Inc. The Company is very pleased to have reached an agreement with such a qualified and committed buyer at a facility valuation that is comparable to recently announced transactions in the renal industry. The Company is confident that National Renal Institutes is as committed as Fresenius Medical Care and Renal Care Group to continuing to provide high-quality care for its patients while the Company accomplishes a smooth and prompt transition that supports its employees and affiliated physicians. The Company looks forward to completing its merger with Renal Care Group, which is targeted to close on or before March 31, 2006, subject to meeting all closing conditions including final approval by the FTC. Following the completion of the acquisition of Renal Care Group, Fresenius Medical Care will own and operate approximately 1,500 dialysis clinics in North America, which will serve approximately 115,000 patients. Fresenius AG (WKN 578560, 578563) holds approximately 37% of Fresenius Medical Care AG & Co. KGaA’s capital. Fresenius Medical Care AG & Co. KGaA, Represented by Fresenius Medical Care Management AG, Board of Management, Bad Homburg v.d.H., February 15, 2005 (c)DGAP 15.02.2006 ————————————————————————— language: English emitter: Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Deutschland phone: +49 (0) 6172- 609 2525 fax: +49 (0) 6172- 609 2301 email: ir-fms@fmc-ag.com WWW: www.fmc-ag.de ISIN: DE0005785802, DE0005785836, WKN: 578580, 578583 indexes: DAX stockmarkets: Amtlicher Markt in Frankfurt; Freiverkehr in Berlin-Bremen, Hannover, Stuttgart, München, Hamburg, Düsseldorf; Foreign Exchange(s) NYSE End of News DGAP News-Service —————————————————————————